NewLimit Funding & Investors
NewLimit specializes in treating age-related diseases to extend the human health span. It works on developing epigenetic reprogramming medicines to treat diseases with large unmet needs.
newlimit.comTotal Amount Raised: $40,000,000
NewLimit Funding Rounds
Series A
$40,000,000
Series A Investors
Fred EhrsamEric SchmidtDimensionGarry TanElad GilKleiner Perkins Caufield & ByersFounders Fund
Funding info provided by Diffbot.